Cholamandalam Investment & Finance Company Ltd (CHOLAFIN) Q1 FY27 Results Analysis: PAT Jumps 45.6%, Stage 3 Rises 24 bps
Cholamandalam Investment & Finance Company Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 8,833.38 Cr (+21.90% YoY) and PAT growth of +45.57% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 28, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 8,833.38 Cr (+21.90% YoY) |
| PAT (Q1) | Rs. 1,653.59 Cr (+45.57% YoY) |
| EPS (Q1) | Rs. 19.40 (+43.67% YoY) |
| Market cap | Rs. 153,631.92 Cr |
| CMP | Rs. 1,801.80 |
Quarter Snapshot
CHOLAFIN delivered strong Q1 results with 21.9% revenue growth and 45.6% PAT growth, driven by operating leverage and margin expansion. AUM grew 22.5% YoY, within guidance, while credit costs remained contained. However, asset quality saw a modest deterioration with Stage 3 rising 24 bps QoQ, warranting monitoring.
Key Investment Insights
Key Positives
- Revenue grew 21.9% YoY to Rs.8,932.95 Cr, PAT grew 45.6% YoY to Rs.1,653.59 Cr.
- PPOP grew 29.3% YoY, with cost-to-income improving 118 bps to 43.28%.
- AUM grew 22.5% YoY to Rs.2,54,392 Cr, within the guided range of 20-23%.
- Credit costs contained: impairment grew only 4.5% YoY despite 22% AUM growth.
- Others segment PBT surged 115% YoY, showing new business scale-up.
- Capital adequacy ratio improved to 19.81% from 19.21% QoQ, well above regulatory minimum.
- Net worth grew 29.9% YoY to Rs.32,078 Cr, driven by retained earnings and CCD conversion.
Risk Factors
- Gross Stage 3 increased to 3.29% from 3.05% QoQ, GNPA increased to 4.50% from 4.36% QoQ.
- Provision coverage ratio (Stage 3) declined to 45.73% from 47.29% QoQ.
- LAP and Home Loans asset growth (17% and 23% YoY) lagged the 25-30% FY27 guidance, though one quarter is insufficient to judge full-year trajectory.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.